80 related articles for article (PubMed ID: 26718128)
1. Hispolon inhibits breast cancer cell migration by reversal of epithelial-to-mesenchymal transition via suppressing the ROS/ERK/Slug/E-cadherin pathway.
Zhao Z; Sun YS; Chen W; Lv LX; Li YQ
Oncol Rep; 2016 Feb; 35(2):896-904. PubMed ID: 26718128
[TBL] [Abstract][Full Text] [Related]
2. Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-κB/slug/E-cadherin pathway.
Zhou P; Wang C; Hu Z; Chen W; Qi W; Li A
BMC Cancer; 2017 Dec; 17(1):813. PubMed ID: 29202800
[TBL] [Abstract][Full Text] [Related]
3. Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway.
Yang B; Huang J; Xiang T; Yin X; Luo X; Huang J; Luo F; Li H; Li H; Ren G
J Appl Toxicol; 2014 Jan; 34(1):105-12. PubMed ID: 24122885
[TBL] [Abstract][Full Text] [Related]
4. Kaempferol, a phytoestrogen, suppressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cells.
Lee GA; Choi KC; Hwang KA
Environ Toxicol Pharmacol; 2017 Jan; 49():48-57. PubMed ID: 27902959
[TBL] [Abstract][Full Text] [Related]
5. Antroquinonol from Antrodia Camphorata suppresses breast tumor migration/invasion through inhibiting ERK-AP-1- and AKT-NF-κB-dependent MMP-9 and epithelial-mesenchymal transition expressions.
Lee WT; Lee TH; Cheng CH; Chen KC; Chen YC; Lin CW
Food Chem Toxicol; 2015 Apr; 78():33-41. PubMed ID: 25656647
[TBL] [Abstract][Full Text] [Related]
6. Depletion of mitochondrial reactive oxygen species downregulates epithelial-to-mesenchymal transition in cervical cancer cells.
Shagieva G; Domnina L; Makarevich O; Chernyak B; Skulachev V; Dugina V
Oncotarget; 2017 Jan; 8(3):4901-4913. PubMed ID: 27902484
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
8. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
Lee HK; Lee DS; Park JC
BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
[TBL] [Abstract][Full Text] [Related]
10. Cross Talk Mechanism among EMT, ROS, and Histone Acetylation in Phorbol Ester-Treated Human Breast Cancer MCF-7 Cells.
Kamiya T; Goto A; Kurokawa E; Hara H; Adachi T
Oxid Med Cell Longev; 2016; 2016():1284372. PubMed ID: 27127545
[TBL] [Abstract][Full Text] [Related]
11. Hispolon from Phellinus linteus has antiproliferative effects via MDM2-recruited ERK1/2 activity in breast and bladder cancer cells.
Lu TL; Huang GJ; Lu TJ; Wu JB; Wu CH; Yang TC; Iizuka A; Chen YF
Food Chem Toxicol; 2009 Aug; 47(8):2013-21. PubMed ID: 19477214
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
[TBL] [Abstract][Full Text] [Related]
13. Hispolon suppresses migration and invasion of human nasopharyngeal carcinoma cells by inhibiting the urokinase-plasminogen activator through modulation of the Akt signaling pathway.
Ho HY; Ho YC; Hsieh MJ; Yang SF; Chuang CY; Lin CW; Hsin CH
Environ Toxicol; 2017 Feb; 32(2):645-655. PubMed ID: 27037602
[TBL] [Abstract][Full Text] [Related]
14. Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway.
Li H; Huang J; Yang B; Xiang T; Yin X; Peng W; Cheng W; Wan J; Luo F; Li H; Ren G
Toxicol Appl Pharmacol; 2013 Oct; 272(1):180-90. PubMed ID: 23707762
[TBL] [Abstract][Full Text] [Related]
15. Hispolon induces apoptosis in human gastric cancer cells through a ROS-mediated mitochondrial pathway.
Chen W; Zhao Z; Li L; Wu B; Chen SF; Zhou H; Wang Y; Li YQ
Free Radic Biol Med; 2008 Jul; 45(1):60-72. PubMed ID: 18423410
[TBL] [Abstract][Full Text] [Related]
16. Phloroglucinol suppresses metastatic ability of breast cancer cells by inhibition of epithelial-mesenchymal cell transition.
Kim RK; Suh Y; Yoo KC; Cui YH; Hwang E; Kim HJ; Kang JS; Kim MJ; Lee YY; Lee SJ
Cancer Sci; 2015 Jan; 106(1):94-101. PubMed ID: 25456733
[TBL] [Abstract][Full Text] [Related]
17. Hispolon suppresses SK-Hep1 human hepatoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen activator through the PI3K/Akt and ERK signaling pathways.
Huang GJ; Yang CM; Chang YS; Amagaya S; Wang HC; Hou WC; Huang SS; Hu ML
J Agric Food Chem; 2010 Sep; 58(17):9468-75. PubMed ID: 20698552
[TBL] [Abstract][Full Text] [Related]
18. Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways.
Yang Q; Ji M; Guan H; Shi B; Hou P
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1909-17. PubMed ID: 24106286
[TBL] [Abstract][Full Text] [Related]
19. Hispolon Induces Apoptosis, Suppresses Migration and Invasion of Glioblastoma Cells and Inhibits GBM Xenograft Tumor Growth In Vivo.
Liao KF; Chiu TL; Chang SF; Wang MJ; Chiu SC
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361649
[TBL] [Abstract][Full Text] [Related]
20. Annurca apple polyphenol extract promotes mesenchymal-to-epithelial transition and inhibits migration in triple-negative breast cancer cells through ROS/JNK signaling.
Vuoso DC; D'Angelo S; Ferraro R; Caserta S; Guido S; Cammarota M; Porcelli M; Cacciapuoti G
Sci Rep; 2020 Sep; 10(1):15921. PubMed ID: 32985606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
